Veselības centru apvienība dentist Ģirts Bīriņš awarded at the Annual Medical Awards
Dentist Ģirts Bīriņš from Veselības centru apvieniba (VCA) “Smaida clinic” was awarded the “Dentist of the Year 2024” award at the Annual Medical Awards ceremony organized by the Latvian Medical Association.
Read more
Central Laboratory board member Jeļena Storoženko receives special award at LMA “Medical Award of the Year 2024”
Jeļena Storoženko, board member of the Baltic region's most modern clinical laboratory, Central Laboratory, and Associate Professor at Riga Stradiņš University, has received a special award from the Latvian Medical Association (LMA) “Medical Award of the Year 2024” for her significant contribution to medical education and laboratory diagnostics development through the publication of “Laboratory Tests in the Diagnosis of Various Diseases.”
Read more
Central Laboratory opens its 102nd Branch in Latgale District, Riga
Central Laboratory has opened its 102nd branch, located at 4A Grēdu Street in Riga, taking another step toward its goal of providing quality laboratory services to the widest possible range of people.
Read more
The renovated stained-glass artwork at Mēness Aptieka “Kamēlija” honored at the prestigious Latvian Construction of the Year Award
The artwork with the historically symbolic title for Latvia – “Song” – was awarded 2nd place in the “Restoration” category at the 2024 Latvian Construction of the Year Awards, which took place in March 2025.
Read more
A safe and supportive environment for patients: the importance of collaboration between psychiatrists and pharmacists
To improve knowledge and understanding of the care of people with mental and behavioural disorders, pharmacists from “Mēness aptieka” visited the National Centre for Mental Health on 27 February.
Read more
Mental health balance is fragile. It’s important to recognise the problem.
During the expert discussion “Mental Health Balance. Boundaries. How to recognise, understand and help?”, organised by “Mēness aptieka”, which focused on early recognition of mental disorders and ways to get timely help, experts stressed the importance of being honest with oneself and not pretending the problem doesn`t exist.
Read more
“Olpha” submits 38 new medicines for EU registration; three new medicines already available to patients in the Baltics
The Latvian pharmaceutical company Olpha continues to work intensively on developing its product portfolio and expanding its exports in the European Union (EU).
Read more
Central Laboratory in Ikšķile opens its 101st branch, improving access to laboratory tests in the region
Central Laboratory has expanded its branch network by opening a new sample collection point in Ikšķile, at 4 Skolas Street (entrance from Stacijas Street), in the municipal multifunctional service center.
Read more
Olpha JSC renews ISO 14001:2015 certification with extended energy assessment
In January this year, the Latvian pharmaceutical manufacturer Olpha AS has successfully renewed its ISO 14001:2015 certification for its environmental management system, which is complemented by a continuous energy consumption assessment process.
Read more
“Mēness aptieka” has received the “Family-friendly workplace” recognition from the Social Integration Foundation
Working for a pharmacy company is a very responsible and important job, because the pharmaceutical care provided to a customer involves the most important thing for them and their families – their health.
Read more
The historic stained-glass artwork “Song” by Tennis Grasis was officially unveiled at the Mēness aptieka “Kamēlija”.
On 16 January, during the reopening of the Mēness aptieka “Kamelija” after its remarkable reconstruction, the stained-glass artwork “Song” by the famous Latvian artist Tenis Grasis was unveiled.
Read more
One in six parents has observed a mental health problem in their child, experts urge urgent search for effective solutions
The mental health of children and young people has deteriorated in recent years. One in six Latvian parents, or 16%, say they have observed mental or mental and physical health problems in their children.
Read more
“Meness aptieka” pharmacists gain knowledge on patient care after knee and hip surgery
Pharmacists from “Mēness aptieka” visited the surgical clinic “AIWA Clinic” to gain a deeper understanding of the therapeutic processes involved in the care of patients after knee and hip replacement surgery, with a particular focus on the care of patients with diabetes.
Read more
For the second year, all newborns in Olaine receive special baby care packages
Continuing its collaboration with the Olaine Municipality, the Latvian pharmaceutical company AS “Olpha” has provided another 200 baby care packages to families in the Olaine region.
Read more
At the "Olpha" conference, healthcare professionals were introduced to updates in urology, neurology, psychiatry, clinical research, and pharmacotherapy
On November 15, nearly 200 healthcare professionals from across Latvia attended the conference Together for Health: Closer to You, organized by "Olpha," to learn about advancements in various fields of medicine.
Read more
The expert discussion organized by “Mēness aptieka” addressed the challenges of diabetes and obesity
In recognition of World Diabetes Day in November “Mēness aptieka” organised an expert discussion titled: “Obesity and diabetes: Treating one, preventing the other.”
Read more
New Chemistry and Biology Teacher Scholarships: "Olpha" and "Central Laboratory" Have Already Invested 45,000 Euros
On October 24 of this year, at the second annual Science Teachers' Day held by the Latvian pharmaceutical company "Olpha," four new scholarships were awarded to aspiring chemistry and biology teachers, each worth 3,000 euros.
Read more
250 patients will have the opportunity to receive obesity treatment at the “AIWA clinic”
An experienced team of medical professionals from the multi-profile surgical clinic “AIWA Clinic”, part of “Veselības centru apvienība” (VCA), will implement the European Union (EU) funded pilot project “Value-based (VBHC) bariatric service model”, promoted by the National Health Service until October 2025.
Read more
With an Investment of 3.56 Million Euros, "Olpha" Establishes One of the Largest Solar Panel Parks on a Manufacturing Company Site
On Wednesday, October 2, in the presence of the Minister of Climate and Energy, Kaspars Melnis, one of Latvia's largest solar panel parks on a manufacturing company site was inaugurated at the premises of Latvia’s leading pharmaceutical manufacturer, "Olpha".
Read more
Published a textbook on laboratory diagnostics, unique in Latvia
A comprehensive textbook titled “Laboratory investigations for the diagnosis of various diseases” was published this week. This textbook, the first of its kind in Latvia, compiles the most important information on advanced diagnostic tests and their medical interpretation.
Read more
"Olpha's" Corporate Social Responsibility Projects Nominated for Prestigious International Pharmaceuticals Award
The corporate social responsibility projects implemented by Latvia's pharmaceutical company "Olpha" have gained recognition on the global stage. The company has been nominated for the 11th annual "Global Generics and Biosimilars Awards" in the category of "Corporate Social Responsibility." The winners will be announced on October 9 in Milan, Italy.
Read more
“Mēness aptieka”- the most loved, highest quality and most affordable brand in the pharmaceutical sector
“Mēness aptieka” has convincingly secured first place in the largest brand and lifestyle survey in the Baltics, “Brand Capital”, and is recognized as the most loved brand in the pharmaceutical sector. In recent years, there has been a significant increase in the number of people who love and appreciate the brand. At the same time, the brand is growing strongly as respondents acknowledge its quality and affordability.
Read more
Olainfarm transforms into Olpha, aiming to become Europe's TOP 10 pharmaceutical company
Olainfarm JSC, a leading Latvian pharmaceutical company and drug manufacturer, announced a rebranding to Olpha on June 19 The company's development strategy is to grow from a regional player to an international pharmaceutical company and Olpha aims to become one of the top ten pharmaceutical companies in Europe...
Read more
“Mēness aptieka” stresses the importance of environmental factors in maintaining health
Every June, with heart health in mind, “Mēness aptieka” raises important issues about cardiovascular diseases and their prevention, conducts public opinion polls and, in cooperation with doctors and the patient organisation, encourages greater use of prevention options and brings forth important topics for discussions relating to heart health.
Read more
People have laboratory tests as prescribed by their GP or specialist
Residents of Latvia follow the instructions of their doctors and have the tests prescribed by their GP or specialist carried out in a laboratory.
Read more
Pharmacists observe heart surgery at the Latvian Centre of Cardiology
In order to better understand the treatment processes of patients with cardiovascular diseases while providing much needed pharmaceutical care, pharmacists from “Mēness aptieka” met with specialists from the Latvian Centre of Cardiology...
Read more
“Veselības centru apvienība” opens an Early Atherosclerosis and Dyslipidaemia Office
The Early Atherosclerosis and Dyslipidaemia Office has been opened in the “Aura” polyclinic of “Veselības centru apvienība” (VCA).
Read more
Six young chemistry and biology teachers in Latvia are awarded scholarships of 18 000 euros
Latvia faces a shortage of teachers, with a critical situation emerging, particularly in natural sciences and technology (STEM).
Read more
Director of Strategic and Health Policy Joins the Management Team of AB CITY Group
In order to further improve AB CITY Group's operations, Kristine Jučkoviča, Director of Strategic and Health Policy, has joined the management team, complementing the centralised management of functions within the holding company.
Read more
AS AB CITY starts the mandatory buy-back of AS Olainfarm shares
In order to ensure that AS Olainfarm shareholders have the opportunity to receive fair value for their shares, the mandatory buy-back of AS Olainfarm shares is currently taking place. It is being conducted in accordance with the provisions of the Republic of Latvia’s Financial Instrument Market Law, and is being overseen by the Financial and Capital Market Commission (FCMC).
Read more
FCMC allows mandatory Olainfarm share buy-back to go ahead
Today, 3 November, the Repharm Group’s parent company AS AB City has received permission from the Financial and Capital Market Commission (FCMC) to go ahead and make a mandatory AS Olainfarm share buy-back offer.
Read more
AB City submits the Olainfarm share buy-back prospectus to the FCMC
AS AB City has made an application to the Financial and Capital Market Commission (FCMC) to make a mandatory buy-back offer for the shares in AS Olainfarm.
Read more
The Purchase of Olainfarm Shares Announced by AB City Has Been Completed
On Wednesday, August 25, the purchase of Olainfarm shares announced by AB City was completed...
Read more
Olainfarm Share Buyback – Green Light from Court
Today, Olainfarm Share Buyback got another green light from Court and AB City buyback offer to shareholders can go ahead unhampered...
Read more
JSC “AB City” offers to purchase JSC “Olainfarm” shares from shareholders
From 19 to 25 August 2021, JSC “AB City” offers to repurchase JSC “Olainfarm” shares owned by shareholders.
Read more
The mandatory Olainfarm share buy-back concluded
Olainfarm minority shareholders have sold sharesworth almost EUR 22.5 million to AB City
Read more
“AB City” will provide minority shareholders of Olainfarm with an opportunity to sell their shares for the price approved by FCMC
JSC “AB City” appreciates the efforts of the Financial and Capital Market Commission (FCMC) to protect minority shareholders of JSC “Olainfarm”, who wish to use the mandatory share repurchase bid...
Read more
“AB City” announces extension of the tender offer for “Olainfarm” shares
JSC “Repharm” parent company JSC “AB City” has announced its readiness to continue purchasing the JSC “Olainfarm” shares owned by minority shareholders also after the end of the period of the mandatory tender offer for JSC “Olainfarm” shares, expiring on 17 August...
Read more
FCMC permits JSC “AB City” to make a mandatory repurchase offer for shares of JSC “Olainfarm”
The Financial and Capital Market Commission has decided to permit JSC “AB City” to make a mandatory repurchase offer for shares of JSC “Olainfarm”, because JSC “AB City”, based on the indirectly acquired ownership...
Read more
“Repharm” group will ask for FCMC’s permission to make a mandatory share repurchase offer to the shareholders of “Olainfarm”
“Repharm” group has informed Nasdaq Riga of an agreement with Nika Saveļjeva to acquire 7.8% of the voting rights in JSC “Olainfarm” by exercising these rights through JSC “AB City”, the mother company of JSC “Repharm”...
Read more